on Biophytis (EPA:ALBPS)
Biophytis to Engage in Major Healthcare and Investment Events
Biophytis SA, a leader in developing therapies for longevity, is set to participate in two significant industry events this January 2026. The company will first attend the 44th JP Morgan Healthcare Conference in San Francisco, from January 12 to 15. This event is renowned as the largest global healthcare investment forum, featuring key figures from the pharmaceutical, biotechnology, and medical technology sectors alongside international investors.
Additionally, Biophytis will join the Biomed Forum organized by All Invest Securities in Paris on January 29. This gathering unites biotech and medtech enterprises with French and European institutional investors focused on healthcare. At these events, Biophytis plans to update attendees on their latest operational and clinical developments, as well as their strategic outlook for 2026.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Biophytis news